Maria Luisa Gasparri1,2, Thorsten Kuehn3, Ilary Ruscito4, Veronica Zuber5, Rosa Di Micco5,6, Ilaria Galiano5, Siobana C Navarro Quinones7, Letizia Santurro5, Francesca Di Vittorio5, Francesco Meani1, Valerio Bassi1, Nina Ditsch8, Michael D Mueller9, Filippo Bellati4, Donatella Caserta4, Andrea Papadia1,2, Oreste D Gentilini4. 1. Department of Gynecology and Obstetrics, Ospedale Regionale di Lugano EOC, via Tesserete 46, 6900 Lugano, Switzerland. 2. Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), via Giuseppe Buffi 13, 6900 Lugano, Switzerland. 3. Interdisciplinary Breast Center, Department of Gynecology and Obstetrics, Klinikum Esslingen, 73730 Neckar, Germany. 4. Gynecology Division, Department of Medical and Surgical Sciences and Translational Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, via di Grottarossa 1035, 00189 Rome, Italy. 5. Breast Surgery Unit, Department of Surgery, San Raffaele University Hospital, via Olgettina 60, 20132 Milan, Italy. 6. Department of Clinical Medicine and Surgery, University of Naples Federico II, 80138 Naples, Italy. 7. Emory University, Atlanta, GA 30322, USA. 8. Department of Gynecology and Obstetrics, University Hospital of Augsburg, Stenglinstraße 2, 86156 Augsburg, Germany. 9. Department of Obstetrics and Gynecology, University Hospital of Bern, Friedbühlstrasse 19, 3010 Bern, Switzerland.
Abstract
BACKGROUND: use of fibrin sealants following pelvic, paraaortic, and inguinal lymphadenectomy may reduce lymphatic morbidity. The aim of this meta-analysis is to evaluate if this finding applies to the axillary lymphadenectomy. METHODS: randomized trials evaluating the efficacy of fibrin sealants in reducing axillary lymphatic complications were included. Lymphocele, drainage output, surgical-site complications, and hospital stay were considered as outcomes. RESULTS: twenty-three randomized studies, including patients undergoing axillary lymphadenectomy for breast cancer, melanoma, and Hodgkin's disease, were included. Fibrin sealants did not affect axillary lymphocele incidence nor the surgical site complications. Drainage output, days with drainage, and hospital stay were reduced when fibrin sealants were applied (p < 0.0001, p < 0.005, p = 0.008). CONCLUSION: fibrin sealants after axillary dissection reduce the total axillary drainage output, the duration of drainage, and the hospital stay. No effects on the incidence of postoperative lymphocele and surgical site complications rate are found.
BACKGROUND: use of fibrin sealants following pelvic, paraaortic, and inguinal lymphadenectomy may reduce lymphatic morbidity. The aim of this meta-analysis is to evaluate if this finding applies to the axillary lymphadenectomy. METHODS: randomized trials evaluating the efficacy of fibrin sealants in reducing axillary lymphatic complications were included. Lymphocele, drainage output, surgical-site complications, and hospital stay were considered as outcomes. RESULTS: twenty-three randomized studies, including patients undergoing axillary lymphadenectomy for breast cancer, melanoma, and Hodgkin's disease, were included. Fibrin sealants did not affect axillary lymphocele incidence nor the surgical site complications. Drainage output, days with drainage, and hospital stay were reduced when fibrin sealants were applied (p < 0.0001, p < 0.005, p = 0.008). CONCLUSION: fibrin sealants after axillary dissection reduce the total axillary drainage output, the duration of drainage, and the hospital stay. No effects on the incidence of postoperative lymphocele and surgical site complications rate are found.
Entities:
Keywords:
axillary lymphadenectomy; breast cancer; fibrin sealant; lymphatic morbidity; lymphocele
Authors: Maria Luisa Gasparri; Ilary Ruscito; Daniele Bolla; Pierluigi Benedetti Panici; Michael D Mueller; Andrea Papadia Journal: Int J Gynecol Cancer Date: 2017-07 Impact factor: 3.437
Authors: Walter Paul Weber; Christoph Tausch; Stefanie Hayoz; Mathias Konrad Fehr; Karin Ribi; Hanne Hawle; Judith Eva Lupatsch; Klazien Matter-Walstra; Federica Chiesa; Konstantin Johannes Dedes; Gilles Berclaz; Loic Lelièvre; Thomas Hess; Uwe Güth; Verena Pioch; Dimitri Sarlos; Cornelia Leo; Claudia Canonica; Natalie Gabriel; Jasmin Zeindler; Estelle Cassoly; Christiane Andrieu; Savas Deniz Soysal; Thomas Ruhstaller; Peter Martin Fehr; Michael Knauer Journal: Ann Surg Oncol Date: 2018-06-08 Impact factor: 5.344
Authors: T Roderick Hester; James R Shire; Davis B Nguyen; Zachary E Gerut; Achih H Chen; Jason Diamond; Julian C Desmond; Laura Silvati-Fidell; Steve Zvi Abrams; Rod J Rohrich Journal: Aesthet Surg J Date: 2013-04-05 Impact factor: 4.283